NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171 | -1.7% | 23,588 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $174 | +3.6% | 23,355 | -3.4% | 0.00% | 0.0% |
| Q1 2023 | $168 | -32.5% | 24,183 | -0.1% | 0.00% | -50.0% |
| Q4 2022 | $249 | -99.9% | 24,201 | -5.8% | 0.00% | -33.3% |
| Q3 2022 | $468,000 | -21.2% | 25,695 | +122.6% | 0.00% | -25.0% |
| Q2 2022 | $594,000 | -45.7% | 11,541 | -22.2% | 0.00% | -33.3% |
| Q1 2022 | $1,093,000 | -45.8% | 14,834 | +5.2% | 0.01% | -33.3% |
| Q4 2021 | $2,017,000 | -44.0% | 14,095 | -18.9% | 0.01% | -52.6% |
| Q3 2021 | $3,603,000 | +88.8% | 17,378 | +93.3% | 0.02% | +72.7% |
| Q2 2021 | $1,908,000 | +52.0% | 8,988 | +29.8% | 0.01% | +57.1% |
| Q1 2021 | $1,255,000 | +119.8% | 6,923 | +35.3% | 0.01% | +133.3% |
| Q4 2020 | $571,000 | +72.0% | 5,117 | +66.8% | 0.00% | +50.0% |
| Q3 2020 | $332,000 | – | 3,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |